Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Body Composition Comparison Between TDF and TAF Regimens in People Living with HIV in Thailand
TCTR20260601010Phase 3Not yet recruiting
- Sponsor
- Fogarty International Center
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate, tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by Fogarty International Center. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
tenofovir disoproxil fumaratetenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on TCTR20260601010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260601010.